Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 5.90E+3nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 9.50E+3nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
TargetCytochrome P450(Homo sapiens (Human))
Bristol-Myers Squibb Research And Development
Curated by ChEMBL
Bristol-Myers Squibb Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human CYP450More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:For Cyp inhibition, human liver microsomes from BD Gentest were incubated with Compound 028 or Compound 032 (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.01 &...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of human CYP2C18 expressed in Sacchrosomes by fluorescence based assayMore data for this Ligand-Target Pair
Affinity DataIC50: >2.00E+4nMAssay Description:Inhibition of human CYP2C18 expressed in Sacchrosomes by fluorescence based assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 6.50E+4nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 1.25E+5nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+5nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+5nMAssay Description:Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strainMore data for this Ligand-Target Pair